917494
NanoFabTx™ device accessory
tubing, 250 μm FEP, 10 m, with ferrules
Synonym(s):
Microfluidic kit, NanoFabTx™, Nanoformulation
Sign Into View Organizational & Contract Pricing
All Photos(2)
About This Item
UNSPSC Code:
41105100
NACRES:
NA.23
Recommended Products
description
Microfludic hardware kit component: Tubing 10m, 250um FEP with ferrules x 1
Quality Level
application(s)
advanced drug delivery
General description
NanoFabTx™ device accessory, tubing, 250 μm FEP with ferrules, 10m is a component of our NanoFabTx™ microfluidic device kits (911593, 911860, 911879). The kits additionally include a protocol, manifold, and additional accessories for microfluidic-based synthesis. Fluorinated ethylene propylene (FEP) is a tough, flexible copolymer of tetrafluoroethylene and hexafluoropropylene, ideal for fluid processing equipment when chemical resistance, high purity, and low stiffness are required.
Application
Legal Information
NANOFABTX is a trademark of Sigma-Aldrich Co. LLC
related product
Product No.
Description
Pricing
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Samar Damiati et al.
Genes, 9(2) (2018-02-22)
Microfluidic devices present unique advantages for the development of efficient drug carrier particles, cell-free protein synthesis systems, and rapid techniques for direct drug screening. Compared to bulk methods, by efficiently controlling the geometries of the fabricated chip and the flow
Xuanyu Li et al.
Advanced drug delivery reviews, 128, 101-114 (2017-12-27)
Microfluidic chips allow the rapid production of a library of nanoparticles (NPs) with distinct properties by changing the precursors and the flow rates, significantly decreasing the time for screening optimal formulation as carriers for drug delivery compared to conventional methods.
Andrew Gdowski et al.
Journal of nanobiotechnology, 16(1), 12-12 (2018-02-13)
The process of optimization and fabrication of nanoparticle synthesis for preclinical studies can be challenging and time consuming. Traditional small scale laboratory synthesis techniques suffer from batch to batch variability. Additionally, the parameters used in the original formulation must be
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service